As of May 14, 2026, Johnson & Johnson's top three insider holders are Alex Gorsky (Chairman, Ceo, 766.58K shares), Joaquin Duato (Ceo And Chairman Of The Board, 324.45K shares), Jennifer L Taubert (Evp, Wwc. Innovative Medicine, 194.45K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Alex Gorsky | Chairman, Ceo | 766,584 | 0 | 18 Jan, 2023 |
| Joaquin Duato | Ceo And Chairman Of The Board | 324,447 | 0 | 18 Feb, 2026 |
| Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 18 Feb, 2026 |
| Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 18 Feb, 2026 |
| Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 18 Feb, 2026 |
| Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 16 Feb, 2022 |
| Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 16 Feb, 2022 |
| Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 16 Feb, 2022 |
| Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 18 Feb, 2026 |
| Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 18 Feb, 2026 |
| Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 18 Feb, 2026 |
| Peter Fasolo | Exec Vp, Chief Hr Officer | 112,076 | 0 | 15 Feb, 2024 |
| Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 15 Feb, 2023 |
| Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 15 Feb, 2023 |
| Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 15 Feb, 2023 |
| Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 25 Aug, 2023 |
| Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 25 Aug, 2023 |
| Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 25 Aug, 2023 |
| Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 16 Feb, 2022 |
| Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 16 Feb, 2022 |
| Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 16 Feb, 2022 |
| William Hait | - | 38,647 | 0 | 15 Feb, 2024 |
| Joaquin Duato | Ceo And Chairman Of The Board | 0 | 30,852 | 28 Jan, 2026 |
| James D. Swanson | Evp, Cio | 25,698 | 0 | 18 Feb, 2026 |
| James D. Swanson | Evp, Cio | 25,698 | 0 | 18 Feb, 2026 |
| James D. Swanson | Evp, Cio | 25,698 | 0 | 18 Feb, 2026 |
| Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 23 Feb, 2026 |
| Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 23 Feb, 2026 |
| Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 23 Feb, 2026 |
| Robert J Decker | Vp Corporate Controller | 23,682 | 0 | 03 Mar, 2026 |
| Elizabeth Forminard | Evp, Chief Legal Officer | 23,568 | 0 | 18 Feb, 2026 |
| Vanessa Broadhurst | Evp, Global Corp Affairs | 23,003 | 0 | 18 Feb, 2026 |
| Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 18 Feb, 2026 |
| Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 18 Feb, 2026 |
| Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 18 Feb, 2026 |
| Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 18 Feb, 2026 |
| Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 18 Feb, 2026 |
| Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 18 Feb, 2026 |
| John C Reed | Evp, Innovative Medicine, Rd | 10,658 | 0 | 18 Feb, 2026 |
| John C Reed | Evp, Innovative Medicine, Rd | 10,658 | 0 | 18 Feb, 2026 |
| John C Reed | Evp, Innovative Medicine, Rd | 10,658 | 0 | 18 Feb, 2026 |
| John G Morikis | - | 1,849 | 0 | 01 Dec, 2025 |
| Mark A Weinberger | - | 1,000 | 0 | 12 Dec, 2024 |
| Mark A Weinberger | - | 1,000 | 0 | 12 Dec, 2024 |
| Mark A Weinberger | - | 1,000 | 0 | 12 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 27 Feb, 2026 | Robert J Decker | Common Stock | A | 4,075 | $115.67 | 27,757 | D | M |
| 27 Feb, 2026 | Robert J Decker | Common Stock | D | 4,075 | $247.87 | 23,682 | D | S |
| 27 Feb, 2026 | Robert J Decker | Employee Stock Options (Right to Buy) | D | 4,075 | $0.00 | 0 | D | M |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 13 Feb, 2026 | Kristen Mulholland | Common Stock | A | 410 | $0.00 | 16,819 | D | M |
| 13 Feb, 2026 | Jennifer L Taubert | Common Stock | A | 1,302 | $0.00 | 179,315 | D | M |
| 13 Feb, 2026 | Timothy Schmid | Common Stock | A | 499 | $0.00 | 22,624 | D | M |
| 13 Feb, 2026 | Joaquin Duato | Common Stock | A | 3,469 | $0.00 | 279,436 | D | M |
| 15 Feb, 2026 | John C Reed | Common Stock | A | 1,349 | $0.00 | 12,007 | D | M |
| 13 Feb, 2026 | Kathryn E Wengel | Common Stock | A | 651 | $0.00 | 106,607 | D | M |
| 13 Feb, 2026 | James D. Swanson | Common Stock | A | 447 | $0.00 | 19,298 | D | M |
| 13 Feb, 2026 | Robert J Decker | Common Stock | A | 312 | $0.00 | 21,313 | D | M |
| 13 Feb, 2026 | Elizabeth Forminard | Common Stock | A | 651 | $0.00 | 16,199 | D | M |
| 13 Feb, 2026 | Joseph J Wolk | Common Stock | A | 37,463 | $0.00 | 51,463 | D | M |
| 13 Feb, 2026 | Vanessa Broadhurst | Common Stock | A | 408 | $0.00 | 24,002 | D | M |